デフォルト表紙
市場調査レポート
商品コード
1442872

モバイルヘルス(mHealth)の世界市場:業界分析、規模、シェア、成長、動向、予測(2023年~2031年)

mHealth Market (Product: Connected Medical Devices, mHealth Applications, and mHealth Services; and End-user: B2B and B2C) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 289 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
モバイルヘルス(mHealth)の世界市場:業界分析、規模、シェア、成長、動向、予測(2023年~2031年)
出版日: 2024年01月03日
発行: Transparency Market Research
ページ情報: 英文 289 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

モバイルヘルス(mHealth)市場

世界のモバイルヘルス(mHealth)市場に関する当レポートは、過去と現在の成長動向、および2023年~2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。当レポートは、2017年~2031年のモバイルヘルス(mHealth)世界市場の収益を提供します。2023年を基準年、2031年を予測年とみなし、2023年~2031年までのモバイルヘルス(mHealth)世界市場の複合年間成長率(CAGR %)も提供します。

当レポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、 モバイルヘルス(mHealth)市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界のモバイルヘルス(mHealth)市場の競合情勢を詳しく掘り下げています。世界のモバイルヘルス(mHealth)市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のモバイルヘルス(mHealth)市場企業の属性です。

目次

第1章 エグゼクティブサマリー

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • 市場セグメンテーション
  • 概要
  • 市場力学
  • 世界市場の分析と予測(2017年~2031年)

第5章 重要な洞察

  • パイプライン分析
  • COVID-19パンデミックが業界に与える影響

第6章 市場分析と予測:製品別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:製品別(2017年~2031年)
    • コネクテッド医療機器
    • 用途
    • サービス
  • 市場の魅力度:製品別

第7章 世界市場の分析と予測:エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:エンドユーザー別(2017年~2031年)
    • B2B
    • B2C
  • 市場の魅力度:エンドユーザー別

第8章 世界市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別(2017年~2031年)
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度:地域別

第9章 北米市場の分析と予測

第10章 欧州市場の分析と予測

第11章 アジア太平洋市場の分析と予測

第12章 ラテンアメリカ市場の分析と予測

第13章 中東・アフリカ市場の分析と予測

第14章 競合情勢

  • 市場企業 - 競合マトリックス(階層別・企業規模別)
  • 市場シェア分析:企業別(2022年)
  • 企業プロファイル
    • Dexcom, Inc.
    • Apple, Inc.
    • FitBit, Inc.
    • Withings
    • Proteus Digital Health, Inc.
    • Omada Health, Inc.
    • Welldoc, Inc.
    • Teladoc Health, Inc.
    • Noom, Inc.
    • Propeller Health.
    • Canary Health
    • BiogeniQ Inc.
    • Glooko, Inc.
    • Firstbeat Technologies
    • BioTelemetry, Inc.
図表

List of Tables

  • Table 01: Global mHealth Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global mHealth Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global mHealth Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America mHealth Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 05: North America mHealth Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 06: North America mHealth Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 07: Europe mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 08: Europe mHealth Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 09: Europe mHealth Market Value (US$ Mn) Forecast, by End-user 2017-2031
  • Table 10: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 11: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 12: Asia Pacific mHealth Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Latin America mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Latin America mHealth Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Latin America mHealth Market Value (US$ Mn) Forecast, by End-user 2017-2031
  • Table 16: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 18: Middle East & Africa mHealth Market Value (US$ Mn) Forecast, by End-user 2017-2031

List of Figures

  • Figure 01: Global mHealth Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global mHealth Market Value Share, by Product, 2022
  • Figure 03: Global mHealth Market Value Share, by End-user, 2022
  • Figure 04: Global mHealth Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 05: Global mHealth Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 06: Global mHealth Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 07: Global mHealth Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 08: Global mHealth Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 09: Global mHealth Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 10: North America mHealth Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 11: North America mHealth Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 12: North America mHealth Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 13: North America mHealth Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 14: North America mHealth Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 15: North America mHealth Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 16: North America mHealth Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 17: Europe mHealth Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 18: Europe mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 19: Europe mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 20: Europe mHealth Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 21: Europe America mHealth Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 22: Europe mHealth Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 23: Europe mHealth Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 24: Asia Pacific mHealth Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 25: Asia Pacific mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 26: Asia Pacific mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 27: Asia Pacific mHealth Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 28: Asia Pacific America mHealth Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 29: Asia Pacific mHealth Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 30: Asia Pacific mHealth Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 31: Latin America mHealth Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 32: Latin America mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 33: Latin America mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Latin America mHealth Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 35: Latin America mHealth Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 36: Middle East & Africa mHealth Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 37: Middle East & Africa mHealth Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Middle East & Africa America mHealth Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 39: Middle East & Africa America mHealth Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 40: Middle East & Africa mHealth Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 41: Middle East & Africa mHealth Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 42: Global mHealth Market Share Analysis, by Company (2022)
目次
Product Code: TMRGL36707

mHealth Market - Scope of Report

TMR's report on the global mHealth market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global mHealth market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mHealth market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the mHealth market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mHealth market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mHealth market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mHealth market.

The report delves into the competitive landscape of the global mHealth market. Key players operating in the global mHealth market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mHealth market profiled in this report.

Key Questions Answered in Global mHealth market Report:

  • What is the sales/revenue generated by wearable injectors across all regions during the forecast period?
  • What are the opportunities in the global mHealth market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

mHealth Market - Research Objectives and Research Approach

The comprehensive report on the global mHealth market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global mHealth market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mHealth market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global mHealth Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global mHealth Market Analysis and Forecasts, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. COVID-19 Pandemic Impact on Industry

6. mHealth Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Connected Medical Devices
      • 6.3.1.1. Heart Rate Monitors
      • 6.3.1.2. Activity Monitors
      • 6.3.1.3. Electrocardiograph
      • 6.3.1.4. Fetal Monitoring
      • 6.3.1.5. Neuromonitoring
      • 6.3.1.6. Others
    • 6.3.2. mHealth Applications
      • 6.3.2.1. Fitness & Wellness
      • 6.3.2.2. Diabetes
      • 6.3.2.3. Cardiovascular Diseases
      • 6.3.2.4. Central Nervous System Diseases
      • 6.3.2.5. Respiratory Diseases
      • 6.3.2.6. Musculoskeletal Diseases
      • 6.3.2.7. Smoking Cessation
      • 6.3.2.8. Medication Adherence
      • 6.3.2.9. Others
    • 6.3.3. mHealth Services
  • 6.4. Market Attractiveness, by Product

7. Global mHealth Market Analysis and Forecast, by End-user

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. B2B
      • 7.3.1.1. Patients
      • 7.3.1.2. Caregivers
    • 7.3.2. B2C
      • 7.3.2.1. Providers
      • 7.3.2.2. Payers
      • 7.3.2.3. Employers
      • 7.3.2.4. Others
  • 7.4. Market Attractiveness, by End-user

8. Global mHealth Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region, 2017-2031
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness, by Region

9. North America mHealth Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product, 2017-2031
    • 9.2.1. Connected Medical Devices
      • 9.2.1.1. Heart Rate Monitors
      • 9.2.1.2. Activity Monitors
      • 9.2.1.3. Electrocardiograph
      • 9.2.1.4. Fetal Monitoring
      • 9.2.1.5. Neuromonitoring
      • 9.2.1.6. Others
    • 9.2.2. mHealth Applications
      • 9.2.2.1. Fitness & Wellness
      • 9.2.2.2. Diabetes
      • 9.2.2.3. Cardiovascular Diseases
      • 9.2.2.4. Central Nervous System Diseases
      • 9.2.2.5. Respiratory Diseases
      • 9.2.2.6. Musculoskeletal Diseases
      • 9.2.2.7. Smoking Cessation
      • 9.2.2.8. Medication Adherence
      • 9.2.2.9. Others
    • 9.2.3. mHealth Services
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. B2B
      • 9.3.1.1. Patients
      • 9.3.1.2. Caregivers
    • 9.3.2. B2C
      • 9.3.2.1. Providers
      • 9.3.2.2. Payers
      • 9.3.2.3. Employers
      • 9.3.2.4. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe mHealth Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Connected Medical Devices
      • 10.2.1.1. Heart Rate Monitors
      • 10.2.1.2. Activity Monitors
      • 10.2.1.3. Electrocardiograph
      • 10.2.1.4. Fetal Monitoring
      • 10.2.1.5. Neuromonitoring
      • 10.2.1.6. Others
    • 10.2.2. mHealth Applications
      • 10.2.2.1. Fitness & Wellness
      • 10.2.2.2. Diabetes
      • 10.2.2.3. Cardiovascular Diseases
      • 10.2.2.4. Central Nervous System Diseases
      • 10.2.2.5. Respiratory Diseases
      • 10.2.2.6. Musculoskeletal Diseases
      • 10.2.2.7. Smoking Cessation
      • 10.2.2.8. Medication Adherence
      • 10.2.2.9. Others
    • 10.2.3. mHealth Services
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. B2B
      • 10.3.1.1. Patients
      • 10.3.1.2. Caregivers
    • 10.3.2. B2C
      • 10.3.2.1. Providers
      • 10.3.2.2. Payers
      • 10.3.2.3. Employers
      • 10.3.2.4. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific mHealth Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Connected Medical Devices
      • 11.2.1.1. Heart Rate Monitors
      • 11.2.1.2. Activity Monitors
      • 11.2.1.3. Electrocardiograph
      • 11.2.1.4. Fetal Monitoring
      • 11.2.1.5. Neuromonitoring
      • 11.2.1.6. Others
    • 11.2.2. mHealth Applications
      • 11.2.2.1. Fitness & Wellness
      • 11.2.2.2. Diabetes
      • 11.2.2.3. Cardiovascular Diseases
      • 11.2.2.4. Central Nervous System Diseases
      • 11.2.2.5. Respiratory Diseases
      • 11.2.2.6. Musculoskeletal Diseases
      • 11.2.2.7. Smoking Cessation
      • 11.2.2.8. Medication Adherence
      • 11.2.2.9. Others
    • 11.2.3. mHealth Services
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. B2B
      • 11.3.1.1. Patients
      • 11.3.1.2. Caregivers
    • 11.3.2. B2C
      • 11.3.2.1. Providers
      • 11.3.2.2. Payers
      • 11.3.2.3. Employers
      • 11.3.2.4. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America mHealth Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Connected Medical Devices
      • 12.2.1.1. Heart Rate Monitors
      • 12.2.1.2. Activity Monitors
      • 12.2.1.3. Electrocardiograph
      • 12.2.1.4. Fetal Monitoring
      • 12.2.1.5. Neuromonitoring
      • 12.2.1.6. Others
    • 12.2.2. mHealth Applications
      • 12.2.2.1. Fitness & Wellness
      • 12.2.2.2. Diabetes
      • 12.2.2.3. Cardiovascular Diseases
      • 12.2.2.4. Central Nervous System Diseases
      • 12.2.2.5. Respiratory Diseases
      • 12.2.2.6. Musculoskeletal Diseases
      • 12.2.2.7. Smoking Cessation
      • 12.2.2.8. Medication Adherence
      • 12.2.2.9. Others
    • 12.2.3. mHealth Services
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. B2B
      • 12.3.1.1. Patients
      • 12.3.1.2. Caregivers
    • 12.3.2. B2C
      • 12.3.2.1. Providers
      • 12.3.2.2. Payers
      • 12.3.2.3. Employers
      • 12.3.2.4. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa mHealth Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Connected Medical Devices
      • 13.2.1.1. Heart Rate Monitors
      • 13.2.1.2. Activity Monitors
      • 13.2.1.3. Electrocardiograph
      • 13.2.1.4. Fetal Monitoring
      • 13.2.1.5. Neuromonitoring
      • 13.2.1.6. Others
    • 13.2.2. mHealth Applications
      • 13.2.2.1. Fitness & Wellness
      • 13.2.2.2. Diabetes
      • 13.2.2.3. Cardiovascular Diseases
      • 13.2.2.4. Central Nervous System Diseases
      • 13.2.2.5. Respiratory Diseases
      • 13.2.2.6. Musculoskeletal Diseases
      • 13.2.2.7. Smoking Cessation
      • 13.2.2.8. Medication Adherence
      • 13.2.2.9. Others
    • 13.2.3. mHealth Services
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. B2B
      • 13.3.1.1. Patients
      • 13.3.1.2. Caregivers
    • 13.3.2. B2C
      • 13.3.2.1. Providers
      • 13.3.2.2. Payers
      • 13.3.2.3. Employers
      • 13.3.2.4. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 14.2. Market Share Analysis, by Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. Dexcom, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Apple, Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. FitBit, Inc.
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Withings
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Proteus Digital Health, Inc.
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Strategic Overview
    • 14.3.6. Omada Health, Inc.
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Welldoc, Inc.
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Strategic Overview
    • 14.3.8. Teladoc Health, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Noom, Inc.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Strategic Overview
    • 14.3.10. Propeller Health.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
    • 14.3.11. Canary Health
      • 14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. Financial Overview
      • 14.3.11.4. SWOT Analysis
      • 14.3.11.5. Strategic Overview
    • 14.3.12. BiogeniQ Inc.
      • 14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.12.2. Product Portfolio
      • 14.3.12.3. Financial Overview
      • 14.3.12.4. SWOT Analysis
      • 14.3.12.5. Strategic Overview
    • 14.3.13. Glooko, Inc.
      • 14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.13.2. Product Portfolio
      • 14.3.13.3. Financial Overview
      • 14.3.13.4. SWOT Analysis
      • 14.3.13.5. Strategic Overview
    • 14.3.14. Firstbeat Technologies
      • 14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.14.2. Product Portfolio
      • 14.3.14.3. Financial Overview
      • 14.3.14.4. SWOT Analysis
      • 14.3.14.5. Strategic Overview
    • 14.3.15. BioTelemetry, Inc.
      • 14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.15.2. Product Portfolio
      • 14.3.15.3. Financial Overview
      • 14.3.15.4. SWOT Analysis
      • 14.3.15.5. Strategic Overview